Stock listing
NASDAQ:DCPH Deciphera Pharmaceuticals LLC Stock
Follow Deciphera Pharmaceuticals LLC into a list and get an email when it puts out news.
Last close · NASDAQ:DCPH
$25.59 USD
Close on Jun 10, 2024 · No longer trades
- Lowest – highest close
- $3.62 – $86.04 USDSince Dec 8, 2016 · lowest Dec 14, 2016 · highest Sep 1, 2017
Delisted NASDAQ:DCPH no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:DCPH
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Deciphera Pharmaceuticals LLC on 6ix
- Decks
- 3 decks · latest Nov 12, 2020
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| CTOS Annual Meeting 2020 | Conference | 14 slides | Nov 12, 2020 |
| Investor Presentation (January 2020) | Investor deck | 35 slides | Jan 13, 2020 |
| Technical Presentation (September 2019) | Technical | 18 slides | Sep 30, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ron Squarer Other companies: Nuvalent, Inc. (Director · Since at least Dec 10, 2025); ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Travere Therapeutics, Inc. (Director · Since at least May 14, 2021) | Director · Jan 15, 2021 – Jun 11, 2024 · Past |
| James Bristol Other companies: Erasca, Inc. (Board Director · Since at least Jan 1, 2024); Ernexa Therapeutics Inc. (Chairman · Since at least Oct 30, 2023) | Director · Jun 11, 2024 – Jun 11, 2024 · Past |
| Dashyant Dhanak Other companies: Incyte Corporation (EVP & Chief Scientific Officer · Dec 10, 2018 – Jul 14, 2023 · Past) | EVP & Chief Scientific Officer · Sep 5, 2023 – Jun 11, 2024 · Past |
| Edward J Benz Jr Other companies: Candel Therapeutics, Inc. (Director · Since at least Jun 26, 2024) | Director · Jun 11, 2024 – Jun 11, 2024 · Past |
| Matthew L Sherman Other companies: Palvella Therapeutics, Inc. (Director · Jun 25, 2021 – Jun 21, 2023 · Past) | EVP & Chief Medical Officer · Oct 2, 2020 – Jun 11, 2024 · Past |
| Thomas Patrick Kelly Other companies: Xenon Pharmaceuticals Inc. (Chief Financial Officer · Since at least Oct 15, 2025) | Chief Financial Officer · May 1, 2019 – Jun 11, 2024 · Past |
| Daniel C Martin | Chief Commercial Officer · Sep 18, 2018 – Jun 11, 2024 · Past |
| Daniel Lee Flynn | Chief Scientific Officer · Sep 27, 2017 – Jun 16, 2023 · Past |
| Dennis Leo Walsh | Director · Sep 27, 2017 – Jun 11, 2024 · Past |
| Franklin Stuart Friedman | Director · Nov 25, 2019 – Jun 11, 2024 · Past |
All 11 people
| Person | Seat |
|---|---|
| Oliver Rosen | Chief Medical Officer · Sep 27, 2017 – Oct 2, 2017 · Past |
Log in to ask 6ix AI your own questions about Deciphera Pharmaceuticals LLC.